U.S. markets close in 5 hours 26 minutes

Precipio, Inc. (PRPO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9426-0.0574 (-1.43%)
As of 10:33AM EDT. Market open.

Precipio, Inc.

4 Science Park
3rd Floor
New Haven, CT 06511
United States
203 787 7888
http://www.precipiodx.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees54

Key Executives

NameTitlePayExercisedYear Born
Mr. Ilan DanieliFounder, Pres, CEO & Director334.89kN/A1972
Mr. Carl R. IbergerCFO & Sec.302.58kN/A1953
Mr. Ahmed Zaki SabetChief Operating Officer168.79kN/A1987
Mr. Ayman Mohamed M.D.Sr. VP of R&D and Laboratory Operations192.11kN/A1986
Ms. Miri Chiko-RadomskiGen. CounselN/AN/AN/A
Mr. Douglas SitesVP of SalesN/AN/AN/A
Mr. Ori KarevChief Strategy OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.

Corporate Governance

Precipio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.